PDS showcases ProteinMentor platform capabilities
The end-to-end characterization solution offers rapid AI-driven analysis, streamlined workflows, and reduced timelines for pre-clinical candidate selection in biopharmaceutical development.
See the latest news and media coverage for PDS. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical protein analytics company
pdsbio.comLast updated
The end-to-end characterization solution offers rapid AI-driven analysis, streamlined workflows, and reduced timelines for pre-clinical candidate selection in biopharmaceutical development.
The facility features the ProteinMentor® platform using AI and hyperspectral imaging to streamline biopharma R&D, ensuring compliance and reducing time to market for therapeutic proteins.
This May 21, 2026 event showcases innovative pharmaceutical analysis products designed to de-risk drug selection and accelerate market entry.
Launched at PEGS Boston, the QCL microscope accelerates drug developability assessments and reduces time to market starting June 1.
WAKEFIELD, MA - Jul 16, 2018 - Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for structural characterization of therapeutic proteins, was recognized by...
Track PDS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to PDS and other trending companies.